Skip to content

Biodesix, Inc. BDSX Accounts Payable

Accounts Payable at other companies

NeoGenomics logo
NeoGenomicsNEO
$25.9M+59.8%
Veracyte logo
VeracyteVCYT
$6.91M-56.0%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$9.62M+51.1%
Personalis, Inc. logo
Personalis, Inc.PSNL
$12.68M+60.2%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$41.02M-53.8%
GeneDx Holdings logo
GeneDx HoldingsWGS
$11.17M-29.6%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+462%
Enterprise value$279.56M+198%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s accounts payable?
Biodesix, Inc. (BDSX) reported accounts payable of $3.65M in Q1 2026.
How has Biodesix, Inc.'s accounts payable changed year-over-year?
Biodesix, Inc.'s accounts payable increased by 24.8% year-over-year, from $2.93M to $3.65M.
What is the long-term trend for Biodesix, Inc.'s accounts payable?
Over 5 years (2020 to 2025), Biodesix, Inc.'s accounts payable has grown at a -19.2% compound annual growth rate (CAGR), from $8.96M to $3.08M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.